Ivan B Filippenkov
Overview
Explore the profile of Ivan B Filippenkov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
147
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Filippenkov I, Remizova J, Denisova A, Stavchansky V, Golovina K, Gubsky L, et al.
Sci Rep
. 2023 Jan;
13(1):573.
PMID: 36631528
Ischemic stroke is one of the most severe polygenic brain diseases. Here, we performed further functional genetic analysis of the processes occurring in the contralateral hemisphere (CH) after ischemia-reperfusion injury...
12.
Stavchansky V, Filippenkov I, Remizova J, Denisova A, Mozgovoy I, Gubsky L, et al.
Genes (Basel)
. 2022 Dec;
13(12).
PMID: 36553646
Glyprolines are Gly-Pro (GP)- or Pro-Gly (PG)-containing biogenic peptides. These peptides can act as neutrophil chemoattractants, or atheroprotective, anticoagulant, and neuroprotective agents. The Pro-Gly-Pro (PGP) tripeptide is an active factor...
13.
Filippenkov I, Remizova J, Denisova A, Stavchansky V, Golovina K, Gubsky L, et al.
Int J Mol Sci
. 2022 Jul;
23(13).
PMID: 35806305
Ischemic stroke is a multifactorial disease with a complex etiology and global consequences. Model animals are widely used in stroke studies. Various controls, either brain samples from sham-operated (SO) animals...
14.
Limborska S, Filippenkov I
Genes (Basel)
. 2022 Mar;
13(3).
PMID: 35327969
Stroke is a multifactorial disease and an extremely serious and socially important medical condition [...].
15.
Limborska S, Filippenkov I
Transl Cancer Res
. 2022 Feb;
8(Suppl 2):S126-S129.
PMID: 35117081
No abstract available.
16.
Filippenkov I, Stavchansky V, Denisova A, Valieva L, Remizova J, Mozgovoy I, et al.
Genes (Basel)
. 2021 Dec;
12(12).
PMID: 34946819
Ischemic brain stroke is one of the most serious and socially significant diseases. In addition to messenger RNAs (mRNAs), encoding protein, the study of regulatory RNAs in ischemic has exceptional...
17.
Filippenkov I, Stavchansky V, Glazova N, Sebentsova E, Remizova J, Valieva L, et al.
Int J Mol Sci
. 2021 Sep;
22(18).
PMID: 34576218
Natural melanocortins (MCs) have been used in the successful development of drugs with neuroprotective properties. Here, we studied the behavioral effects and molecular genetic mechanisms of two synthetic MC derivatives-ACTH(4-7)PGP...
18.
Sudarkina O, Filippenkov I, Stavchansky V, Denisova A, Yuzhakov V, Sevankaeva L, et al.
Int J Mol Sci
. 2021 Jul;
22(12).
PMID: 34201112
The Semax (Met-Glu-His-Phe-Pro-Gly-Pro) peptide is a synthetic melanocortin derivative that is used in the treatment of ischemic stroke. Previously, studies of the molecular mechanisms underlying the actions of Semax using...
19.
Dergunova L, Filippenkov I, Limborska S, Myasoedov N
Med Res Rev
. 2020 Jul;
41(2):754-769.
PMID: 32638434
Here we present a review of studies on the effects of peptides with neuroprotective properties on gene transcription in nerve cells. The few published works in this area clearly demonstrate...
20.
Filippenkov I, Stavchansky V, Denisova A, Yuzhakov V, Sevankaeva L, Sudarkina O, et al.
Genes (Basel)
. 2020 Jun;
11(6).
PMID: 32580520
Cerebral ischaemia is the most common cause of impaired brain function. Biologically active peptides represent potential drugs for reducing the damage that occurs after ischaemia. The synthetic melanocortin derivative, ACTHPGP...